Related Experiment Video

Updated: May 11, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Effect of pre-procedural statin therapy on myocardial no-reflow following percutaneous coronary intervention: a meta

Xiang-dong Li1, Yue-jin Yang, Yong-chen Hao

  • 1Department of Evidence Based Medicine, Fuwai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China. greenmountain_709@yahoo.com.cn

Chinese Medical Journal
|May 9, 2013
PubMed

Insights

Pre-procedural statin therapy significantly reduces the incidence of no-reflow phenomenon after percutaneous coronary intervention (PCI). This benefit is particularly notable with acute intensive statin regimens, suggesting routine use before PCI may improve outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • No-reflow phenomenon complicates successful revascularization in coronary artery disease, especially ST-elevation myocardial infarction (STEMI).
  • Pre-procedural statin administration is hypothesized to mitigate myocardial no-reflow post-percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To systematically review and synthesize evidence on the efficacy of pre-procedural statin therapy in reducing myocardial no-reflow after PCI.

Main Methods:

  • A comprehensive literature search of MEDLINE, Cochrane, and clinicaltrials.gov databases was conducted up to October 2012.
  • Included randomized controlled trials initiated statins prior to PCI and reported myocardial no-reflow outcomes.
  • Random-effects meta-analysis using the DerSimonian-Laird model was employed to calculate summary risk ratios.

Main Results:

  • Seven studies comprising 3086 patients met the inclusion criteria.
  • Pre-procedural statins significantly decreased post-PCI no-reflow by 4.2% in all PCI patients (RR 0.56, P=0.016).
  • A notable reduction of 5.0% was observed in non-STEMI patients (RR 0.41, P=0.035), primarily with acute intensive statin therapy (RR 0.43, P=0.001).

Conclusions:

  • Acute intensive statin therapy administered before PCI significantly lowers the risk of post-procedural no-reflow.
  • Routine consideration of statin use prior to PCI is recommended to improve reperfusion outcomes.
Abstract

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...